Detalhe da pesquisa
1.
Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.
JAMA;
320(19): 1998-2009, 2018 11 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30357272
2.
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
Intensive Care Med;
50(1): 68-78, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38172296
3.
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury.
BMJ Open;
13(4): e065613, 2023 04 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37012016
4.
Pesticide Exposure of Residents Living Close to Agricultural Fields in the Netherlands: Protocol for an Observational Study.
JMIR Res Protoc;
10(4): e27883, 2021 Apr 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33908892
5.
Mechanistic Effect Modeling of Earthworms in the Context of Pesticide Risk Assessment: Synthesis of the FORESEE Workshop.
Integr Environ Assess Manag;
17(2): 352-363, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32910508
6.
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
Intensive Care Med;
50(4): 614-615, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38436728